Improved and Standardized Approaches to Selection of Control Materials From ISIMM: Announcing a Workshop at the Annual ASCP Meeting, September 6-7, 2017, Sponsored by the International Society for Immunohistochemistry and Molecular Morphology

    loading  Checking for direct PDF access through Ovid

Excerpt

The activities of ISIMM (The International Society for Immunohistochemistry and Molecular Morphology) in its foundation year were reviewed by members gathered together at USCAP (United States and Canadian Academy of Pathology) in San Antonio, Texas, in Spring 2017, immediately following the meeting of the Editorial Board of AIMM (Applied Immunohistochemistry and Molecular Morphology). The close affiliation of ISIMM and AIMM is reflected in the “Control Series” and “Evolution Series” of papers published in AIMM over the past several months,1–5 with a focus on improved quality of immunohistochemistry through improved and standardized approaches to selection of control materials. This series follows directly from the 2 earlier papers on the use of positive and negative controls.6,7
The society website (www.isimm.org) is live with information about the Society and is showing encouraging activity. Of the several planned ISIMM-sponsored workshops, 2 have already taken place.
The first workshop was in conjunction with the Asian Pacific International Academy of Pathology, in Bali, Indonesia, in April, with a focus on Quality Control, Diagnostic Panels, and Companion Diagnostics, presented by Mogens Vyberg, Blake Gilks, Allen Gown, and Clive Taylor. These presentations are being made available to members on the ISIMM website. The second workshop was sponsored by NordiQC in Aalborg, Denmark, in June, with participation by ISIMM members; presentations may be found on the NordiQC conference website (www.nordiqc2017.dk).
A third ISIMM workshop organized by Blake Gilks will take place at the Annual American Society of Clinical Pathology (ASCP) meeting in Chicago from September 6-7, 2017, with the title “Real World Immunohistochemistry: What You Need To Know to Successfully Employ It.” The planned program is as follows: “Companion Diagnostics and Personalized Medicine” (C Taylor); “Choice of controls for Immunohistochemistry” (S Nielsen: NordiQC); “Evolution of Quality Assurance for Diagnostic Immunohistochemistry: Validation of New Immunohistochemical Tests” (E Torlakovic: Canadian Immunohistochemistry QC); and “Rational and Effective Use of Antibody Panels” (A Gown).
A fourth meeting has also been finalized now. The program spans 3 and a half days and is titled a Symposium on Immunohistochemistry, January 4-7, 2018. Department of Histopathology, Tata Medical Center, Kolkata, India. It is a joint venture of Tata Pathology, including both ISIMM and NordiQC. Confirmed speakers include David Dabbs, Rohit Bhagarva, Soren Nielsen, Mogens Vyberg, Clive Taylor, and Abhi Gholap, with topics ranging from “undifferentiated primary tumors,” organ-specific IHC, such as that used in breast cancer and lymphoma cases, quality control and proficiency testing, and digital pathology. A fifth meeting is in the final planning stages, being the next in the series of AIMP Annual Retreats, organized by Dr Hadi Yaziji and Pathology Learning Centers to be held in Florida in February 2018.
Further details of these programs together with ISIMM membership information, dues, and how to join ISIMM are available on www.isimm.org. Note that the membership year for ISMM began in July; hence, now is the ideal time to join for the upcoming year.
    loading  Loading Related Articles